Совершенствование формирования Казахстанского национального лекарственного формуляра для повышения рационального использования лекарственных средств

Abstract

Kazakhstan national drug formulary form is defined as - a list of medicines with proven clinical safety and efficacy, as well as orphan (rare) drugs, which is a mandatory basis for the development of medicinal formularies of medical organizations and formation of lists of procurement of medicines within the guaranteed volume of free medical care and in the system of compulsory social health insurance in the Code “On public health and health care system”. Health research data show that in 18% of cases, non-KNF drugs were prescribed in Nur-Sultan medical organizations, 86% of healthcare organizations did not analyze rational use of financial costs for medicines and analyzes of drug consumption, 90% of medicines are assigned by trade name. At the same time, polypharmacy, excessive prescription of antibiotics and injection drugs are noted. The lack of a systematic understanding of the role of CNF in the rational use of drugs reduces the effectiveness of the measures taken. The value of the Kazakhstan National Drug Formulary for the health care of the Republic of Kazakhstan is enormous, for example, for clinicians it is a public resource for doctors and serves as a reference book on medicines and pharmacotherapy based on evidence-based medicine, as well as a guide to integrate Kazakhstan's usual clinical practice into international best practice, in addition to educational a guide providing continuing education in clinical pharmacology and a restrictive list of drugs recommended for routine use in routine clinical practice. For the population, it plays the role of a guideline in the provision of medicines within the guaranteed volume of medical care and in the system of compulsory social health insurance, as well as guidance on involving civil society in the process of monitoring the rational use of medicines. This policy brief shows three policy options and visions for implementing policy options. At the same time, the existing legislative framework of Kazakhstan has all the necessary conditions to support the implementation of the proposed policy options, however, the main barriers to the implementation of policy options may be a lack of human resources, unethical promotion of medicines on the market, lack of support from the authorized body in the field of health, and there is also a lack of understanding by medical workers and the public of the role of the Kazakhstan national formulary in the rational use of medicines